Compare · RGC vs TLRY
RGC vs TLRY
Side-by-side comparison of Regencell Bioscience Holdings Limited (RGC) and Tilray Brands Inc. (TLRY): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both RGC and TLRY operate in Medicinal Chemicals and Botanical Products (Health Care), so they compete in similar markets.
- RGC is the larger of the two at $4.72B, about 10.0x TLRY ($474.4M).
- Over the past year, RGC is down 46.5% and TLRY is down 80.4% - RGC leads by 33.9 points.
- TLRY has been more active in the news (13 items in the past 4 weeks vs 1 for RGC).
- TLRY has more recent analyst coverage (14 ratings vs 0 for RGC).
- Company
- Regencell Bioscience Holdings Limited
- Tilray Brands Inc.
- Price
- -
- -
- Market cap
- $4.72B
- $474.4M
- 1M return
- +63.52%
- -22.77%
- 1Y return
- -46.48%
- -80.42%
- Industry
- Medicinal Chemicals and Botanical Products
- Medicinal Chemicals and Botanical Products
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2021
- 2018
- News (4w)
- 1
- 13
- Recent ratings
- 0
- 14
Tilray Brands Inc.
Tilray, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products. The company operates through five segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, Wellness Business, and Business Under Development. It provides medical and adult-use cannabis products; pharmaceutical and wellness products; beverage alcohol products; and hemp-based food and other wellness products. The company offers its products to retailers, wholesalers, patients, physicians, pharmacies, clinics, hospitals, governments, and researchers. It has operations in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company was formerly known as Aphria Inc. Tilray, Inc. was incorporated in 2018 and is based in New York, New York.
Latest RGC
- SEC Form 20-F filed by Regencell Bioscience Holdings Limited
- SEC Form 4 filed by Director Lo William Wing Yan Dr
- SEC Form 4 filed by Director Hui Evana Yee Wah
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited
- SEC Form 424B5 filed by Regencell Bioscience Holdings Limited
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited
- SEC Form 6-K filed by Regencell Bioscience Holdings Limited
Latest TLRY
- SweetWater Brewing Gives Fans the Chance to Win Tickets to Their Dream Show at AEG Venues Across Georgia
- Tilray Medical Strengthens Global Medical Cannabis Supply Chain with Approval to Bring Critical EU-GMP Quality Testing In-House, Accelerating Product Release Across Regulated Global Markets
- SEC Form 10-Q filed by Tilray Brands Inc.
- SEC Form 8-K filed by Tilray Brands Inc.
- Tilray Brands Delivers Record Q1 Fiscal 2027 Revenue and Record Q1 Gross Profit, Demonstrating the Power of Its Global Platform, Driven by Double-Digit Year-Over-Year Growth Across International Cannabis, Beverage and Pharmaceutical Distribution
- BrewDog’s Winning Streak Rolls on with Gold at the Scottish Beer Awards
- BrewDog Rallies Beer Lovers Across the UK to Choose Craft
- 10 Barrel Expands Salty Sips RTD Portfolio with New Blackberry Refresher
- SEC Form DEFA14A filed by Tilray Brands Inc.
- SEC Form DEF 14A filed by Tilray Brands Inc.